Challenges in diagnosis of polycystic ovary syndrome in adolescence

References

• Witchel S, Oberfield S, Rosenfield R, et al. The diagnosis of polycystic ovary syndrome during adolescence. Horm Res Paediatr. 2015;83(6):376–389.
   Web of Science ®Google Scholar
• Carmina E, Rosato F, Janni A, et al. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab. 2006;91(1):2–6.
   PubMed Web of Science ®Google Scholar
• Rosenfield R. Clinical review: adolescent anovulation: maturational mechanisms and implications. J Clin Endocrinol Metab. 2013;98(9):3572–3583.
   PubMed Web of Science ®Google Scholar
• Moran L, Hutchison S, Norman R, et al. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2011;16:2.
   Google Scholar
• Çoban ÖG, Tulacı ÖD, Adanır AS, et al. Psychiatric disorders, self-esteem, and quality of life in adolescents with polycystic ovary syndrome. J Pediatr Adolesc Gynecol. 2019;32(6):600–604.
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshopgroup Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–47.
   PubMed Web of Science ®Google Scholar
• Rothenberg SS, Beverley R, Barnard E, et al. Polycystic ovary syndrome in adolescents. Best Pract Res Clin Obstet Gynaecol. 2018;48:103–114.
   PubMed Web of Science ®Google Scholar
• Sultan C, Paris F. Clinical expression of polycystic ovary in adolescent girls. Fertil Steril. 2006;86:S6–S6.
   PubMed Web of Science ®Google Scholar
• Fauser B, Tarlatzis R, Rebar R, et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97(1):28–38.
   PubMed Web of Science ®Google Scholar
• Teede H, Misso M, Costello M, et al. recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602–1618.
   PubMed Web of Science ®Google Scholar
• Ramezani F, Amiri M. Polycystic ovary syndrome in adolescents: challenges in diagnosis and treatment. Int J Endocrinol Metab. 2019;17(3):e91554.
   PubMed Web of Science ®Google Scholar
• Pigny P, Jonard S, Robert Y, et al. Serum anti-mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(3):941–994.
   PubMed Web of Science ®Google Scholar
• Sopher A, Grigoriev G, Laura D, et al. Anti-mullerian hormone may be a useful adjunct in the diagnosis of polycystic ovary syndrome in nonobese adolescents. J Pediatri Endocrinol Metab. 2014;27:1175–1179.
   PubMed Web of Science ®Google Scholar
• Brown M, Park AS, Shayya RF, et al. Ovarian imaging by magnetic resonance in adolescent girls with polycystic ovary syndrome and age-matched controls. J Magn Reson Imaging. 2013;38(3):689–693.
   PubMed Web of Science ®Google Scholar
• Asanidze E, Kristesashvili J, Pkhaladze L, et al. The value of anti-Mullerian hormone in the management of polycystic ovary syndrome in adolescents. Gynecol Endocrinol. 2019;35(11):974–977.
   PubMed Web of Science ®Google Scholar
• Villarroel C, Merino PM, Lopez P, et al. Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-mullerian hormone. Hum Reprod. 2011;26(10):2861–2868.
   PubMed Web of Science ®Google Scholar
• Pinola P, Morin-Papunen L, Bloigu A, et al. Anti-Mullerian hormone:correlation with testosterone and oligo- or amenorrhoea in female adolescence in a population-based cohort study. Hum Reprod. 2014;29(10):2317–2325.
   PubMed Web of Science ®Google Scholar
• Nardo L, Yates P, Roberts S, et al. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome. Hum Reprod. 2009;24(11):2917–2923.
   PubMed Web of Science ®Google Scholar
• Tokmak A, Kokanali D, Timur H, et al. Association between anti-Mullerian hormone and insulin resistance in non-obese adolescent females with polycystic ovary syndrome. Gynecol Endocrinol. 2016;32(11):926–930. Nov
   PubMed Web of Science ®Google Scholar
• Park H, Cho G, Ahn K, et al. Association of insulin resistance with anti-Mullerian hormone levels in women without polycystic ovary syndrome (PCOS). Clin Endocrinol. 010;72(1):26–31.
   Google Scholar
• Chen MJ, Yang WS, Chen CL, et al. The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome. Hum Reprod. 2008;23(4):952–957. Apr
   PubMed Web of Science ®Google Scholar
• Calzada M, López N, Noguera JA, et al. AMH in combination with SHBG for the diagnosis of polycystic ovary syndrome. J Obstet Gynaecol. 2019; 39(8):1130–1136.
   PubMedGoogle Scholar
• Witchel S, Oberfield S, Peña A. Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc. 2019;3(8):1545–1573.
   PubMed Web of Science ®Google Scholar
• Ebersole AM, Bonny AE. Diagnosis and treatment of polycystic ovary syndrome in adolescent females. Clin Obstet Gynecol. 2020;63(3):544–552.
   PubMed Web of Science ®Google Scholar
• Asanidze E, Khristesashvili J, Pkhaladze L, et al. Correlation of anti-Mullerian Hormone with hormonal and ovarian morphological characteristics in patients with PCOS and insulin resistance. Georgian Med News. 2018;2:34–40.
   Google Scholar
• Koutlaki N, Dimitraki M, Zervoudis S, et al. The relationship between anti-Mullerian hormone and other reproductive parameters in normal women and in women with polycystic ovary syndrome. J Med Life. 2013;15:6146–6150.
   Google Scholar